Shanmuga Hospital Board of Directors
Get the latest insights into the leadership at Shanmuga Hospital. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Kannan Anjana Maragatham | Company Secretary & Compliance Officer |
| Dhandapani Priyadharshni | Non Executive Director |
| Karuppiah Saravanan | Non Executive Director |
| Gowri | Non Executive Independent Director |
| Bhoopathy Akilan | Non Executive Independent Director |
| Rajkumar Ashwin | Non Executive Independent Director |
| Panneerselvam Palaniappan Shanmugam | Managing Director |
| Prabu Sankar Panneerselvam | Executive Director & Chief Executive Officer |
| Jayalakshmi Panneerselvam | Executive Director |
Shanmuga Hospital FAQs
The board at Shanmuga Hospital consists of experienced professionals, including Kannan Anjana Maragatham, Dhandapani Priyadharshni, and others, overseeing the company’s strategic and corporate governance.
Directors at Shanmuga Hospital are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Kannan Anjana Maragatham is the current chairman at Shanmuga Hospital.
Executive directors at Shanmuga Hospital are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Shanmuga Hospital adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Shanmuga Hospital, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
